Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study).


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 05 2019
Historique:
received: 16 12 2018
revised: 06 02 2019
accepted: 13 02 2019
pubmed: 9 3 2019
medline: 17 1 2020
entrez: 9 3 2019
Statut: ppublish

Résumé

Few data are available about the impact on outcomes of procedural strategies for percutaneous coronary intervention with thin-struts stents on unprotected left main (ULM): 792 patients with an ULM stenosis treated with percutaneous coronary intervention with thin-strut stents were enrolled in the present multicenter registry. Target lesion revascularization (TLR) was the primary end point. MACE (a composite of all-cause death, myocardial infarction, TLR, and stent thrombosis) and its single components, along with target vessel revascularization were the secondary end points. Subgroup analyses were performed according to complex versus noncomplex bifurcation lesions. After 16 months, 5.5% of patients experienced a TLR. At multivariate analysis, provisional stenting (odds ratio [OR] 0.46: 0.85 to 0.23, p = 0.006), use of imaging (OR 0.45: 0.23 to 0.98, p = 0.003) and final kissing balloon (FKB) (OR 0.41: 0.83 to 0.21, p = 0.001) reduced risk of TLR. FKB reduced risk of overall TLR only for 2 stents-strategy (6.2% vs 32.4%, p <0.05), but not for provisional strategy (3.8% vs 3.7%, p = 0.67). Intracoronary imaging reduced risk of overall TLR both for provisional (2.2% vs 5.4%) and for 2-stents strategy (7.3% vs 14.1% p <0.05 for both, all confidence interval 95%). In conclusion, TLR for ULM patients treated with thin-strut stents is infrequent. Provisional stenting was noninferior compared with 2-stents apart from complex lesions. Benefit from intracoronary imaging is consistent for different strategies, whereas that from FKB persists only for 2-stents.

Identifiants

pubmed: 30846212
pii: S0002-9149(19)30218-8
doi: 10.1016/j.amjcard.2019.02.013
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1619

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Fabrizio D'Ascenzo (F)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy. Electronic address: fabrizio.dascenzo@gmail.com.

Pierluigi Omedè (P)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.

Ovidio De Filippo (O)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.

Enrico Cerrato (E)

Department of Cardiology, Infermi Hospital, Rivoli, Italy.

Michele Autelli (M)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.

Daniela Trabattoni (D)

Department of Cardiovascular Sciences, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Nicola Ryan (N)

Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain.

Giuseppe Venuti (G)

Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy.

Saverio Muscoli (S)

Department of Cardiovascular Disease, Tor Vergata University of Rome, Rome, Italy.

Andrea Montabone (A)

Department of Cardiology, S.G. Bosco Hospital, Torino, Italy.

Wojciech Wojakowski (W)

Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.

Andrea Rognoni (A)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Gerard Helft (G)

Sorbonne Université, Institut de Cardiologie, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France.

Diego Gallo (D)

Department of Mechanical and Aerospace Engineering, PolitoBIOMed Lab, Politecnico di Torino, Torino, Italy.

Radoslaw Parma (R)

Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.

Leonardo De Luca (L)

Division of Cardiology, S. Giovanni Evangelista Hospital, Tivoli, Italy.

Filippo Figini (F)

Pederzoli Hospital, Peschiera del Garda, Italy.

Satoru Mitomo (S)

Unit of Cardiovascular Interventions, IRCCS San Raffaele Hospital, Milan, Italy.

Giacomo Boccuzzi (G)

Department of Cardiology, S.G. Bosco Hospital, Torino, Italy.

Alessio Mattesini (A)

Division of Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Wojciech Wańha (W)

Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.

Grzegorz Smolka (G)

Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.

Zenon Huczek (Z)

Medical University of Warsaw, Warsaw, Poland.

Bernardo Cortese (B)

Interventional Cardiology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.

Imad Sheiban (I)

Pederzoli Hospital, Peschiera del Garda, Italy.

Javier Escaned (J)

Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain.

Carloalberto Biolè (C)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.

Federico Conrotto (F)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.

Christian Templin (C)

Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.

Giorgio Quadri (G)

Department of Cardiology, Infermi Hospital, Rivoli, Italy.

Cristina Rolfo (C)

Unità Funzionale Interaziendale di Emodinamica, Ospedale degli Infermi di Rivoli e AOU San Luigi Gonzaga di Orbassano, Turin, Italy.

Davide Capodanno (D)

Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy.

Alaide Chieffo (A)

Unit of Cardiovascular Interventions, IRCCS San Raffaele Hospital, Milan, Italy.

Ivan Nuñez-Gil (I)

Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain.

Umberto Morbiducci (U)

Department of Mechanical and Aerospace Engineering, PolitoBIOMed Lab, Politecnico di Torino, Torino, Italy.

Mario Iannaccone (M)

SS Annunziata Hospital, Cuneo, Italy.

Sebastiano Gili (S)

Department of Cardiovascular Sciences, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Carlo di Mario (CD)

Division of Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Claudio Moretti (C)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.

Maurizio D'Amico (M)

Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy.

Ferdinando Varbella (F)

Department of Cardiology, Infermi Hospital, Rivoli, Italy.

Francesco Romeo (F)

Department of Cardiovascular Disease, Tor Vergata University of Rome, Rome, Italy.

Thomas F Lüscher (TF)

Department of Cardiology, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, Middlesex, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH